PHR1362
Calcium Acetate
Pharmaceutical Secondary Standard; Certified Reference Material
Sinonimo/i:
Calcium acetate
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Formula condensata:
(CH3CO2)2Ca
Numero CAS:
Peso molecolare:
158.17
Numero CE:
Numero MDL:
Codice UNSPSC:
41116107
ID PubChem:
NACRES:
NA.24
Prodotti consigliati
Grado
certified reference material
pharmaceutical secondary standard
Livello qualitativo
agenzia
traceable to USP 1086334
Famiglia di API
calcium acetate
CdA
current certificate can be downloaded
tecniche
HPLC: suitable
gas chromatography (GC): suitable
Impurezze
~1% Acetic acid
applicazioni
pharmaceutical (small molecule)
Formato
neat
Temperatura di conservazione
2-30°C
Stringa SMILE
CC(=O)O[Ca]OC(C)=O
InChI
1S/2C2H4O2.Ca/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2
VSGNNIFQASZAOI-UHFFFAOYSA-L
Cerchi prodotti simili? Visita Guida al confronto tra prodotti
Descrizione generale
Calcium Acetate belongs to the group of calcium salts, widely used as phosphorus binders in patients with chronic renal failure.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Applicazioni
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Nota a piè di pagina
To see an example of a Certificate of Analysis for this material enter LRAA1466 in the slot below. This is an example certificate only and may not be the lot that you receive.
Codice della classe di stoccaggio
11 - Combustible Solids
Classe di pericolosità dell'acqua (WGK)
WGK 1
Punto d’infiammabilità (°F)
Not applicable
Punto d’infiammabilità (°C)
Not applicable
Choose from one of the most recent versions:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Daniel T Grima et al.
Current medical research and opinion, 29(2), 109-115 (2012-12-12)
The avoidance of hospitalizations and the maintenance of in-center dialysis sessions in patients receiving dialysis for end-stage renal disease (ESRD) have obvious benefits to patients, dialysis providers and payers. Benefits include better continuity of care, better patient outcomes, improved quality
Leonardo V Riella et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 57(4), 641-645 (2011-02-22)
Hypophosphatemia is a common complication after kidney transplant, affecting >90% of patients. However, no specific recommendations for phosphate repletion exist for transplant recipients. We report a case of a 70-year-old highly sensitized woman with end-stage renal disease caused by diabetic
Meagan L Harless et al.
Environmental toxicology and chemistry, 30(7), 1637-1641 (2011-04-08)
Widespread and intensive application of road deicers, primarily road salt (NaCl), in North America threatens water quality and the health of freshwater ecosystems. Intensive use of NaCl can be harmful to sensitive members of freshwater ecosystems such as amphibians. Detection
Alastair J Hutchison et al.
Nature reviews. Nephrology, 7(10), 578-589 (2011-09-07)
The ideal serum level of phosphate in patients on dialysis, and the benefits of controlling levels of phosphate in serum remain unclear despite observational studies that associate phosphate levels with mortality. In the absence of robust data from trials, current
Rodrigo B de Oliveira et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28(10), 2510-2517 (2013-08-27)
Mineral bone disorder (MBD) is an early complication of chronic kidney disease (CKD), with complex interactions in the bone-kidney-energy axis. These events lead to impaired bone remodelling, which in turn is associated with cardiovascular disease. Recently, we reported on a
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.